Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00538759 · ClinicalTrials.gov registry record · Phase 2
Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
A Phase 2 study, sponsored by Minneapolis Heart Institute Foundation.
- Terminated
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT00538759: Clinical Trial Phase 2 study, sponsored by Minneapolis Heart Institute Foundation.
NCT00538759 is a Phase 2 study that was terminated before completion, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 21 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00538759, a Phase 2 study, was terminated before completion, sponsored by Minneapolis Heart Institute Foundation.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
The objective of the RADAR trial is to determine the impact of External Beam Radiation Therapy (EBRT) on aortic valve restenosis following successful percutaneous balloon aortic valvuloplasty (BAV) in elderly patients with severe calcific aortic stenosis.
Interventions
- OTHER Sham Control
- DEVICE External beam radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Why NCT00538759 stopped before completion
NCT00538759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Control is the first listed.
NCT00538759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00538759 about?
NCT00538759 is a clinical study titled "Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis". The objective of the RADAR trial is to determine the impact of External Beam Radiation Therapy (EBRT) on aortic valve restenosis following successful percutaneous balloon aortic valvuloplasty (BAV) in elderly patients with severe calcific aortic stenosis.
What is the current status of trial NCT00538759?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2007-09. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00538759?
The interventions under investigation include: Sham Control (OTHER), External beam radiation therapy (DEVICE).
Who is sponsoring clinical trial NCT00538759?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00538759's enrollment target sits among peer trials
21 1794th of 2000 higher than 196 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia